Skip to content
NASDAQ · MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES · LARGE CAP

Novanta Inc. NOVT

17 fiscal years on record · USD · FY2025 reported · SEC filings only
$980.6M
▲ 3.3% YoY
$53.8M
▼ 16.0% YoY
$48.4M
▼ 65.7% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Novanta Inc. is a global supplier of core technology solutions to medical, life science and advanced industrial original equipment manufacturers. As of December 31, 2025, it employed approximately 3,000 people, of which approximately 36% were in the United States, 55% in Europe, and 9% in Asia. During the year ended December 31, 2025, two OEM customers, each operating primarily in the medical end market across multiple product lines, represented approximately 12% and 11%, respectively, of its consolidated revenue. The company reports two reportable segments, identified based on commonality and adjacency of end markets and customers among its individual product lines. The Automation Enabling Technologies segment designs, manufactures and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling and bearing spindles to customers worldwide. The Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, imaging, identification and RFID solutions, advanced motion control solutions, light engines, and integrated operating room technologies. The company was founded and initially incorporated in Massachusetts in 1968 as General Scanning, Inc., which merged with Lumonics Inc. in 1999 to form GSI Lumonics Inc., renamed GSI Group Inc. in 2005 and renamed Novanta Inc. in May 2016.

Written from the business description in NOVANTA INC's annual report to the U.S. Securities and Exchange Commission, filed 23 February 2026. Every sentence was checked against that document before publication.

Growth

USD 980.6M
Revenue, FY2025 · full 17-year series below
Revenue $M Net income $M
FY2025 · Revenue 980.6 · Net income 53.8
400M800M
2009201220152018202120242025
Compound annual growth
+4.4%
+10.7%
+10.1%
+8.6%
−10.1%
+3.9%
+4.2%
−10.6%
+3.3%
+3.7%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +10.7% a year over the five years to FY2025 — but profit grew slower: net income at +3.9%, earnings per share at +3.3%.

The share count rose from 0.04B to 0.04B over the period.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

5 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 9.6% · Net 5.5%
5%10%-10%-20%
200920172025
ROE
FY2025 · ROE 5.2%
10%20%-50%
200920172025
Three returns, three denominators.

Each USD of equity produced 5 cents of profit this year.

Cash & shareholders

USD 39.3M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 48.4
50M100M-10M-20M
200920172025
Net buybacks $M Dividends $M
FY2025 · Dividends · · Net buybacks 39.3
15M30M
201320152016201720182019202020222025

USD 39.3M in buybacks — 73% of the year's profit went back to shareholders.

Total assetsUSD 1.8B
EquityUSD 1.3B
CashUSD 380.9M
Gross debtUSD 250.8M
Net debtUSD -130.0M
Current ratio3.69×

The company holds more cash than debt.

The 17-year record

17 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
NOVT, 17-year financial record
Metric 20252024202320222021202020192018201720162015201420132012201120102009
Revenue $B1.00.90.90.90.70.60.60.60.50.40.40.40.30.20.30.30.3
Operating income $B0.10.10.10.10.10.10.10.10.10.00.0−0.00.00.00.00.0−0.0
EBITDA $B0.20.20.20.20.10.10.10.10.10.10.00.00.00.00.10.1−0.0
Income tax $B0.00.00.00.00.00.00.00.00.00.00.0−0.00.0−0.00.00.0−0.0
Net income $B0.10.10.10.10.10.00.00.00.10.00.0−0.00.00.00.0−0.0−0.1
Free cash flow $B0.00.10.10.10.10.10.10.10.10.00.00.00.00.00.0−0.0−0.0
EPS, diluted $1.471.772.022.061.411.251.151.431.130.631.02−0.700.210.580.86−0.03−4.48
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend—————————————————
ROE %5.29.011.713.510.110.010.414.421.18.715.6−10.73.18.915.0−0.5−84.6
Shares out B0.040.040.040.040.040.040.040.030.030.030.030.030.030.030.030.03◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 1 failure in 83 reconciliationsAUDITED

Reconciled in 16 of the 17 fiscal years we could check. Six checks were skipped: the balance sheet is not tagged before 2010. Two checks were skipped: EPS is not tagged before 2009. Two checks were skipped: revenue is not tagged before 2009.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency1 failure
ActivityMiscellaneous Electrical Machinery, Equipment & Supplies
Listed onNASDAQ
Incorporated inoutside the United States — SEC code A3
Fiscal year endsDecember 31
Data on record since2009

Share this section

Download image